Become a Distributor
Become a Distributor
Edit Content
Request Samples
Become a Distributor

Home

/

About

About

about

The Covalon Story

Welcome to Covalon, where compassion meets innovative technology. Our commitment to transforming healthcare goes beyond technology—it’s about infusing care with empathy, understanding, and a relentless pursuit of excellence. 

With more than 20 years of experience, Covalon has been specializing in vascular access, advanced wound care, and customized medical device coatings. Our journey is marked by our dedication to advancing patient care. 

Solutions Designed with Intention 

Our unique soft-silicone and dual-antimicrobial dressings were designed to be:

  • Gentle
  • Compassionate
  • Robust protection

Advancing Compassionate Care Together 

We are more than a provider: we are your ally. We will continue to:

  • Understand the challenges you face
  • Support your desire for improved patient care
  • Listen to your feedback

Compassionate Products. Exceptional Care.

Our renowned products stand out for their ease of use, comfort, and reliable protection. They are not just products—they are a testament to our unwavering commitment to redefining healthcare standards.

Meet our Leadership Team

Covalon Careers

Careers

At Covalon, we are always looking for talented people to join our growing team of motivated, passionate professionals. We offer opportunities to develop and expand your career, while making a true difference in people’s lives.
JOIN OUR TEAM
JOIN OUR TEAM

[email protected]

US Sales: +1 (206) 513-7604

Toll-Free: +1 (888) 236-4944

1200 Brickell Avenue, Suite 1950 #1138, Miami, Florida, USA, 33131

International Sales: +1 (905) 568-8400

Toll-Free: +1 (877) 711-6055

Fax: (905) 568-5200

1660 Tech Avenue, Unit 5
Mississauga, Ontario, Canada
L4W 5S7

Products

Company

Youtube Facebook-f Instagram Linkedin-in
Disclaimer: Products shown may come in different packaging, package sizes, lettering or markings, and products are available only in the countries or jurisdictions where they are approved for use for the intended indication. Please contact Covalon for more information.
Scroll to Top
Search

Become A Distributor

Brent-Ashton

Brent Ashton

Chief Executive Officer

Icon-linkedin
Brent Ashton was named the Chief Executive Officer of the Corporation on January 4, 2024. Mr. Ashton leads all aspects of strategy and execution for Covalon. Mr. Ashton brought extensive global MedTech leadership experience with him to Covalon. In his most recent role prior to joining Covalon, Mr. Ashton was the Vice President and General Manager for Becton Dickinson’s global Specimen Management Business Group. Prior to joining BD, Mr. Ashton spent 13 years in leadership positions with 3M Health Care where he led global businesses in the areas of Wound Care, Vascular Access, and Infection Prevention. Mr. Ashton has a Bachelor of Arts in Honors Business Administration from the Ivey School of Business at Western University in London, Canada.
Kim Crooks

Kim Crooks

Chief Operating Officer

Icon-linkedin
Kim Crooks rejoined Covalon and was appointed Senior Vice President of Operations effective January 2, 2024. She has been appointed Chief Operating Officer and director of the company effective May 14, 2025. After initially joining the Company in 2008, she retired in 2022 but has been continuing in helping strengthen cross-functional collaborations and external stakeholder relationships on a consultative basis. She has over 20 years of cross-disciplinary experience in the pharmaceutical and medical device industries with international and Canadian companies, including Baxter, Bristol-Myers Squibb, and Vasogen. She has extensive experience in Production, Operations, Quality Assurance, Quality Control, Regulatory, and Clinical Affairs in the US, Canada, and the EU. She holds a Bachelor of Science degree from Carleton University.
Val DiTizio

Val DiTizio

Chief Scientific Officer

Icon-linkedin
Dr. DiTizio is a co‐inventor of Covalon technologies and a co‐founder of the company. He has degrees in science from the University of Toronto as a Biochemistry Specialist. Dr. DiTizio completed his Master’s degree in liposome drug delivery. His graduate research involved the application of polymer chemistry and drug delivery in pursuit of novel materials and processes that currently comprise the core of Covalon’s intellectual property. Dr. DiTizio holds several US and European patents.
Ron Hebert

Ron Hebert

Senior Vice President, Growth

Icon-linkedin

Ron Hebert joined Covalon in 2022 as Senior Vice President of Growth. He brings nearly 30 years of healthcare sales, marketing, and clinical laboratory experience to the team. Before joining Covalon, he served as VP of Marketing and Communications at VIVEX Biologics, a regenerative medicine technology company based in Miami, Florida. He also served as Head of Growth and Sales Operations at MEDNAX (NYSE:MD) Health Solutions, a $3.5B Physician Services Organization. He was responsible for the complete development and execution of the organization’s growth strategies, communications, and sales operations strategies for partner hospitals and health systems, and the more than 400 company-owned physician practices under the organizational sub-brands Pediatrix Medical Group, American Anesthesiology, and MEDNAX Radiology. Prior to MEDNAX, Mr. Hebert served as the Director of Global Product Management and Strategy for Beckman Coulter, a Danaher Company, where he oversaw all global upstream marketing, R&D, and general management of its $700M+ hematology, hemostasis, and urinalysis business. Mr. Hebert has extensive experience leading national and international marketing operations within two prominent global pharmaceutical and medical device companies: Bayer Diagnostics and Siemens Healthineers. He currently serves on the Advisory Board of the University of South Florida Muma College of Business Executive Education Digital Marketing Program.

Greg Leszczynski

Greg Leszczynski

Vice President, Human Resources

Icon-linkedin
Joining Covalon in 2018, Mr. Leszczynski brings with him over 20 years of experience in Human Resources within the technology, healthcare, and financial industries. He has broad experience in all key HR areas, has experience managing global Human Resources and practices, and has a passion for developing leadership within organizations. Throughout his career, Mr. Leszczynski has held various progressive HR positions, including Vice President of Human Resources at Merge Healthcare. Mr. Leszczynski holds an Honours Bachelor of Science from the University of Toronto and is a Certified Human Resources Leader (CHRL).
Katie Martinovich

Katie Martinovich

Interim CFO

Icon-linkedin
Katie Martinovich was appointed Interim CFO effective February 7, 2024. Prior to this, she served as Vice President of Finance and as Corporate Controller since joining Covalon in April 2022. She is an accomplished financial leader with over 20 years of experience in driving cost-saving initiatives, enhancing profitability, and improving operational efficiency. Having a strong background in the Consumer Packaged Goods and manufacturing industries, she has a track record of optimizing financial performance and guiding organizations through periods of growth and change. Ms Martinovich is a Chartered Professional Accountant and holds a Bachelor’s degree in Business Commerce from the University of Athabasca.

Katherine Evely

Vice President, Clinical Affairs

Icon-linkedin
Katherine Evely joined Covalon in 2017 bringing a strong background in biomedical research and medical communications to the team. Since joining the company, Kate has worked to build the Clinical Affairs function within Covalon by establishing strong relationships with key stakeholders and undertaking projects that establish the impact and clinical value of Covalon’s products to patients, clinicians and industry partners. In addition to a PhD from the Jacobs School of Medicine at the State University of New York at Buffalo (University at Buffalo), she holds Bachelor and Master of Science degrees in Pharmacology & Toxicology, and is a Certified Clinical Research Professional (CCRP).
Amir Boloor

Amir Boloor

Executive Chair

Icon-linkedin
Amir Boloor is the President of Caspian Equity Partners, Inc. of Vancouver, British Columbia, a private investment firm he founded in 2012. He has specialized in helping entrepreneurs accelerate growth and optimize performance, while propelling long-term profitability and value. Prior to founding Caspian Equity Partners, Inc., Mr. Boloor held various positions in the Mergers & Acquisitions and Diversified Investment Banking groups of TD Securities, Inc. where he advised Boards and Executive Teams of mid-market and large-cap companies on numerous strategic review mandates, initial public offerings, mergers, acquisitions, divestitures, corporate restructures, leveraged buyouts, and takeover defenses. Mr. Boloor has a Bachelor of Commerce degree in Finance (with Honours) from the University of British Columbia. Mr. Boloor is a Chartered Financial Analyst from the CFA Institute.

Joseph Cordiano

Director

Icon-linkedin

Joseph Cordiano joined Cityzen Development Group, a real estate development company, as a principal in 2006, where he is responsible for the sales and marketing as well as new business development of its Greater Toronto Area projects. While he continues to provide an oversight for legacy projects, he is no longer involved in new initiatives. During his 21 years of public service as a Member of the Ontario Provincial Legislature, Mr. Cordiano served as the Minister of Economic Development and Trade, GTA Regional Minister and as a member of the Priorities and Planning Committee of Cabinet. A graduate of the University of Toronto and The University of Toledo, Ohio, Mr. Cordiano holds an MBA with a specialty in marketing.

Martin Goldfarb

Director

Icon-linkedin

Martin Goldfarb is an entrepreneur and a leading expert in the study of human behavior as it relates to the marketplace and society. He is Chairman of Almada Inc., President of Goldfarb Ventures, private equity companies and Principal at Goldfarb Intelligence Marketing. In 1966, Mr. Goldfarb established Goldfarb Consultants, a market research consulting firm, which he led until the sale of Goldfarb Consultants in 1998. Mr. Goldfarb has consulted to a number of national and international organizations. He also served as official pollster to the Liberal Party of Canada from 1973 to 1992. He was formerly Co-Chair of Kantar (WPP’s market research division). Mr. Goldfarb is Chairman, President and CEO of The Goldfarb Corporation, a TSX and then a NEX Board of the TSX Venture Exchange (“TSX-V”) company, until it became a private corporation in 2011. He was also Director and Chairman of Dayforce, a workforce performance software company until its sale. He was Chairman and Director of SMK Speedy International Inc., then a publicly listed company, until its sale in 2004. He was Director, investor, and non-executive Chair of Jempak until its sale. Mr. Goldfarb is former Director and Chairman of Workbrain and former Director of Altamira and Noma Industries Limited. He was a founder of Fast Company magazine. Mr. Goldfarb co-authored “Marching to a Different Drummer” in 1988 and “Affinity: Beyond Branding” in 2010. Mr. Goldfarb has a B.A. in Anthropology and an M.A. in Sociology from the University of Toronto. In 2009, Mr. Goldfarb was awarded an Honorary Doctorate of Laws from York University. He is an inaugural recipient of the University College, University of Toronto, Distinguished Alumni Award. In 1998, Mr. Goldfarb was designated an Officer of the Order of Canada in recognition of his pioneering work in the market research industry and philanthropic activities. Mr. Goldfarb sits on the Toronto General and Western Hospital Foundation Senate.

Dr. Samantha Nutt

Director

Icon-linkedin
Dr. Samantha Nutt (MD, MSc, CCFP, FCPC, C.M.) is a medical doctor, best-selling author, and award-winning humanitarian. As Founder and President of War Child Canada and War Child USA, Dr. Nutt has worked with children and their families at the frontline of many of the world’s major crises. With a career that has spanned more than two decades and dozens of conflict zones, her international work has benefited millions of war-affected children globally. Dr. Nutt has been appointed to the Order of Canada and is a recipient of the Order of Ontario. She graduated summa cum laude from McMaster University, earned an M.Sc. in Public Health with distinction from the London School of Hygiene and Tropical Medicine, and holds a Fellowship in Community Medicine/Public Health (FRCPC) from the Royal College of Physicians and Surgeons of Canada. She is further certified by the College of Family Practice (CCFP) and completed a sub-specialization in women’s health through the University of Toronto as a Women’s Health Scholar. Dr. Nutt is the recipient of numerous honorary doctorates from universities in Canada and the U.S.A. She is a staff physician at Women’s College Hospital in Toronto and an Assistant Professor of Medicine at the University of Toronto.

Ron Smith

Director

Icon-linkedin
Ron Smith (FCPA, FCA, ICD.D) is an experienced independent director with years of Board experience in the private, not-for-profit, and public sectors. He is the Chair of the Board of the Nova Scotia Public Service Superannuation Fund and of the Western Regional Enterprise Network. He also serves on the boards of Alamos Gold Inc., PROREIT, the IWK Health Centre, Ombudsman for Banking Services and Investments (OBSI), and Engage Nova Scotia. Over his remarkable career, Mr. Smith has held numerous high-profile executive positions. He served as Interim CEO of Nova Scotia Business Inc. concurrently with his work as a Director thereof. He was CFO of Nova Scotia Power and Emera prior to his retirement in 2005, and CFO of MT&T prior to the merger that created Bell Aliant. He has also served on the Board of the Canada Pension Plan Investment Board, was Chair of the Board of Governors of Acadia University from 2004 to 2009, and was the Chair of the National Board of The Arthritis Society from 2016 to 2018. Mr. Smith has the prestigious designation of Fellow of the Chartered Professional Accountants and holds the ICD.D designation from the Rotman School of Business.

Abe Schwartz

Director

Icon-linkedin

Abe Schwartz is the President of Schwartz Technologies Corporation which he founded in 1985 to fund and actively develop early-stage companies engaged in healthcare and information technologies. Mr. Schwartz has been a Director of Covalon Technologies Ltd. since March 7, 2008. Mr. Schwartz has been actively building and managing companies from start-up to successful exit since his first software start-up in 1975. Mr. Schwartz has held executive positions and directorships in a number of public and private companies including CEO of Cedara Software Corp., a medical imaging company. Mr. Schwartz has over 50 years of experience in launching products, research and development, international distribution agreements, corporate reorganizations and turnarounds, venture capital financing and negotiating mergers and acquisitions.